摘要
P2X受体由一个广泛表达的细胞外ATP门控阳离子通道七个成员家族(P2X1-7)构成。因为P2X受体已经涉及到神经系统、炎症和心血管疾病,它们构成了有前景的药物靶标。从第一个P2X cDNA序列在1994年面世开始,为了揭示P2X受体运行和多聚化的关键位点,无数关于定点诱变的研究已广泛开展起来。在同三聚APO-关闭和ATP结合的开放状态下斑马鱼P2X4(zfP2X4)受体的3-A的晶体结构分别在2009年和2012年发表。它为理解特定三维模型中丰富的分子数据、设计出更具判断性的实验的方法带到了一个新的时代。正因为有这些结构,在过去的五年里给我们对P2X受体类配体门控离子通道的结构和功能有更好的理解提供了宝贵的见解。在该综述中,我们概述了能鉴定对配体结合、通道门控、离子流、孔隙和通道闸形成和脱敏起关键作用的氨基酸残基的前晶体结构和后晶体结构的诱变研究。另外,本文基于zfP2X4晶体结构预测的诱变研究和表明接触综述了涉及P2X受体的三聚位点。
关键词: 突变P2X受体分析, P2X组装领域, P2X ATP结合口袋, P2X四级结构, P2X受体功能。
Current Medicinal Chemistry
Title:Key Sites for P2X Receptor Function and Multimerization: Overview of Mutagenesis Studies on a Structural Basis
Volume: 22 Issue: 7
Author(s): Ralf Hausmann, Achim Kless and Gunther Schmalzing
Affiliation:
关键词: 突变P2X受体分析, P2X组装领域, P2X ATP结合口袋, P2X四级结构, P2X受体功能。
摘要: P2X receptors constitute a seven-member family (P2X1-7) of extracellular ATP-gated cation channels of widespread expression. Because P2X receptors have been implicated in neurological, inflammatory and cardiovascular diseases, they constitute promising drug targets. Since the first P2X cDNA sequences became available in 1994, numerous site-directed mutagenesis studies have been conducted to disclose key sites of P2X receptor function and oligomerization. The publication of the 3-A crystal structures of the zebrafish P2X4 (zfP2X4) receptor in the homotrimeric apo-closed and ATP-bound open states in 2009 and 2012, respectively, has ushered a new era by allowing for the interpretation of the wealth of molecular data in terms of specific three-dimensional models and by paving the way for designing more-decisive experiments. Thanks to these structures, the last five years have provided invaluable insight into our understanding of the structure and function of the P2X receptor class of ligandgated ion channels. In this review, we provide an overview of mutagenesis studies of the pre- and post-crystal structure eras that identified amino acid residues of key importance for ligand binding, channel gating, ion flow, formation of the pore and the channel gate, and desensitization. In addition, the sites that are involved in the trimerization of P2X receptors are reviewed based on mutagenesis studies and interface contacts that were predicted by the zfP2X4 crystal structures.
Export Options
About this article
Cite this article as:
Ralf Hausmann, Achim Kless and Gunther Schmalzing , Key Sites for P2X Receptor Function and Multimerization: Overview of Mutagenesis Studies on a Structural Basis, Current Medicinal Chemistry 2015; 22 (7) . https://dx.doi.org/10.2174/0929867322666141128163215
DOI https://dx.doi.org/10.2174/0929867322666141128163215 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances of Fluorescent Technologies for Drug Discovery and Development
Current Pharmaceutical Design <i>Prunella vulgaris</i> L: Critical Pharmacological, Expository Traditional Uses and Extensive Phytochemistry: A Review
Current Drug Discovery Technologies Health Benefits of Ipecac and Cephaeline: their Potential in Health Promotion and Disease Prevention
Current Bioactive Compounds Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine Metabolomics Approach Reveals Altered Plasma Amino Acid and Sphingolipid Profiles Associated with Patholological State in Transition Dairy Cows
Current Metabolomics DNA Damage and Epigenetic Changes in Kidney Diseases - Focused on Transcription Factors in Podocytes
Current Hypertension Reviews Dietary Technologies to Optimize Healing from Injury-Induced Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nutriproteomics – Linking Proteomics Variation with Personalized Nutrition
Current Pharmacogenomics and Personalized Medicine Overcoming hERG Affinity in the Discovery of Maraviroc; A CCR5 Antagonist for the Treatment of HIV
Current Topics in Medicinal Chemistry Optimising the Use of Non-Invasive Ventilation in the Intensive Care Setting
Current Respiratory Medicine Reviews Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
Current Protein & Peptide Science Nicotinamide Adenine Dinucleotide Based Therapeutics
Current Medicinal Chemistry Protein C Inhibitor as an Anti-Disseminated Intravascular Coagulation Agent - Mechanism and Modification
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Neurotoxicity and Side-Effects of Highly Active Antiretroviral Therapy [HAART] on the Central and Peripheral Nerve System
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Processed Foods, Dysbiosis, Systemic Inflammation, and Poor Health
Current Nutrition & Food Science Dental Caries and Vaccination Strategy against the Major Cariogenic Pathogen, Streptococcus mutans
Current Pharmaceutical Biotechnology Use of BNP and CRP as Biomarkers in Assessing Cardiovascular Disease:Diagnosis Versus Risk
Current Vascular Pharmacology Editorial (Thematic Issue: Rheumatic Diseases as the Fuel to Inflamm-aging)
Current Aging Science